TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
GNLX

Genelux Corporation

Healthcare · Biotechnology

2.50$ -3.6% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement GNLX
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0%
8.7% 598.8% 11,287.5% 7,175.0%
91.3% -498.8% -11,187.5% -7,075.0%
82.0% 7,510.0% 237,475.0% 248,137.5%
45.2% 6,804.7% 158,825.0% 167,137.5%
118.5% 13,715.9% 385,012.5% 408,100.0%
-27.2% -14,214.7% -396,200.0% -415,175.0%
12.7% 2,337.6% 0.0%
-37.1% -16,645.3% -373,362.5% -401,812.5%
9.9% 500.1%
-47.0% -16,645.3% -373,362.5% -401,812.5%
-15.6% -15,562.9% -362,075.0% -394,637.5%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?